Trade & Industry Committee

Session 2002-03    15 November 2002


Press Notice 42

TRADE AND INDUSTRY COMMITTEE

  COMMITTEE OFFICE     HOUSE OF COMMONS    7 MILLBANK     LONDON SW1P 3JA

Telephone: 020 7219 5663/5777

Inquiry into the UK Biotechnology Industry

The Trade and Industry Committee announced in March that it would undertake an inquiry to examine the current and future prospects for the UK biotechnology industry, including genomics and related aspects of the pharmaceutical industry. As part of this inquiry, the Committee will take oral evidence on Tuesday 19 November in the Grimond Room, Portcullis House. The witnesses will be: 

10.15    Association of the British Pharmaceutical Industry -

Dr Philip Wright, Director of Science and Technology

Dr Alexander Duncan, Executive Vice President of Drug Discovery, Cambridge Antibody Technology

Dr Gill Sanders, Director of Science Policy, Pfizer Central Research

10.55    MRC Laboratory of Molecular Biology, Cambridge -

Dr Greg Winter, CBE, FRS

11.35    University Technology Transfer Units

Dr Jeff Skinner, UCL Ventures

Dr Ederyn Williams, Warwick Ventures

Note to Editors

The Committee is appointed under Standing Order No. 152 of the House of Commons to examine the expenditure, administration and policy of the Department of Trade and Industry and associated public bodies.  It has the power to send for persons, papers and records.